We fight to improve the lives
of everyone affected by epilepsy

Warning message

This article was published in November 2012. The information may be out of date. Please check our epilepsy information or our site A-Z.

New ‘once a day’ medicine fails to make a difference

22 Nov 2012

A new version of the epilepsy medicine Lyrica (pregabalin) has failed to significantly reduce seizures during tests. The manufacturer Pfizer had hoped the new version of the medicine would mean people taking it just once a day. However, it didn’t show enough of an improvement in reducing seizure frequency.

Pfizer are still testing the once-a-day version of Lyrica for treating other conditions including fibromyalgia and some types of nerve pain.

This news does not affect how the current version of Lyrica should be used for treating epilepsy.

Source: uk.reuters.com and Pharma Times

There are no comments yet. Be the first to comment...

Question about your epilepsy?

Your question will be sent to our helpline advisors.

Have a comment about this page?

All comments are reviewed by a moderator before publishing. Comments will be edited or deleted if they are offensive, libellous, slanderous, abusive, commercial or irrelevant.

We ask for your email when you make a comment through this website. This means that we can let you know directly that we have replied to you. By making a comment through the website, you allow us to use the comment in our publicity without using your name. If we would like to use your name, we will email you to get your permission.

The content of this field is kept private and will not be shown publicly.
This question is for testing whether you are a human visitor and to prevent automated spam submissions.
12 + 0 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.